HOOKIPA Pharma Inc.
HOOK
$0.7896
-$0.0354-4.29%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 118.32% | 143.30% | 227.80% | 235.12% | 41.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 118.32% | 143.30% | 227.80% | 235.12% | 41.27% |
| Cost of Revenue | -27.62% | -10.19% | 16.30% | -9.24% | -2.29% |
| Gross Profit | 92.11% | 86.25% | 68.32% | 79.54% | 14.00% |
| SG&A Expenses | 8.11% | 4.82% | -4.63% | -4.90% | -1.04% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.54% | -5.14% | 8.84% | 12.88% | 20.20% |
| Operating Income | 47.26% | 43.09% | 35.42% | 34.06% | -16.09% |
| Income Before Tax | 46.30% | 37.05% | 28.62% | 28.46% | -25.55% |
| Income Tax Expenses | -128.73% | -62.21% | -62.21% | -62.30% | 60.43% |
| Earnings from Continuing Operations | 46.67% | 37.21% | 28.84% | 28.68% | -25.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.67% | 37.21% | 28.84% | 28.68% | -25.67% |
| EBIT | 47.26% | 43.09% | 35.42% | 34.06% | -16.09% |
| EBITDA | 48.35% | 45.06% | 36.61% | 35.44% | -17.00% |
| EPS Basic | 60.71% | 55.83% | 52.89% | 46.23% | 15.78% |
| Normalized Basic EPS | 61.52% | 71.65% | 66.37% | 59.49% | 26.76% |
| EPS Diluted | 60.19% | 55.27% | 52.38% | 45.70% | 15.77% |
| Normalized Diluted EPS | 61.44% | 71.58% | 66.31% | 59.43% | 26.76% |
| Average Basic Shares Outstanding | 32.65% | 44.78% | 58.22% | 49.20% | 44.38% |
| Average Diluted Shares Outstanding | 32.80% | 44.96% | 58.41% | 49.41% | 44.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
